Journal Clinical Pharmacy // Drug Repurposing

Journal Clinical Pharmacy

Formulary drug reviews

IJCP - International Journal of Clinical Pharmacy was called Pharmacy World & Science till 2010.

The aim of the International Journal of Clinical Pharmacy (IJCP) is to provide a medium for the publication of articles on clinical pharmacy and related practice-oriented subjects in the pharmaceutical sciences. The scope of the journal is clinical pharmacy, its research and its application in e.g. pharmaceutical care. The editors therefore welcome contributions on the above mentioned topics and especially reviews on pharmacotherapy, pharmacoepidemiology, pharmacoeconomics and other clinical aspects of pharmacy.

Editor-in-Chief :

J.W.F. van Mil, Zuidlaren, The Netherlands

IJCP Editorial Board :

Marie Caroline Husson, Hôpital Bicêtre, Le Kremlin Bicêtre, France

Peter A.G.M. de Smet, WINap, The Hague, The Netherlands

International Advisory Board:

The advisory board is composed of clinical pharmacists from across Europe, many of whom are ESCP Members.

Benoit Allenet, Université J Fourier, Grenoble, France; Claire Anderson, University of Nottingham, UK; Anna Birna B. Almarsdottir, University of Iceland, Iceland; Douglas Ball, Pharmaceutical consultant, UK; Simon Bell, University of Kuopio, Kuopio, Finland; Cecilia Britta Bernsten, University of Uppsala, Sweden; Helen Boardman, University of Nottingham, UK; Ton de Boer, Utrecht University, The Netherlands; Ian Boyd, Ian Boyd Consulting, Australia; Greg Duncan, Monash University, Australia; Anders Ekedahl, Linneus University Kalmar, Sweden; R. Fijn, Diaconessenhuis Leiden, The Netherlands; Bryony Dean Franklin, University of London, UK; Andy Gray, University of KwaZulu-Natal, South Africa; Dick R. Gourley, University of Tennessee, USA; Yolande Hanssens, Hamad Medical Corporation, Qatar; Kurt Hersberger, University of Basel, Zwitserland; Carmel Hughes, University of Belfast, Northern Ireland; Mohamed I. Ibrahim, Qassim University, Saudi Arabia; Michelle A. King, Griffith University, Queensland, Australia; Moira Kinnaer, Strathclyde Institute of Pharmacy and Biomedical Sciences, Strathclyde, Scotland; James McElnay, Queens University Belfast, Northern Ireland; Pauline Norris, University of Otago, New Zealand; Hugo Robays, University of Ghent, Belgium; Marion Schaefer, Humboldt University Berlin, Germany; Derek Stewart, The Robert Gordon University, UK; Mary P. Tully, University of Manchester, UK; Albert I. Wertheimer, Temple University, Philadelphia, USA; Tone Westergren, Rikshospitalet Oslo, Norway

You might also like

Aren't "anti-depressants" something!

by silverfish2

Why, they're used to "treat" all kinds of different things, despite those they're not approved for and those lacking credible scientific/medical premises.
""Most off-label drug mentions have little or no scientific support," said study co-author Jack Fincham, A.W. Jowdy Professor of Pharmacy Care at the University of Georgia College of Pharmacy. "And when I say most, it's like 70 to 75 percent. Many patients have no idea that this goes on and just assume that the physician is writing a prescription for their indication."
"The study, published in the

Mosby Introduction to Clinical Pharmacology, 7e
Book (Mosby)
  • Used Book in Good Condition

Pharmacist Provider Status  — Pharmacy Times
In 2000, North Carolina was able to pass legislation that created a clinical pharmacist practitioner (CPP). We were able to work with the medical director for Medicare's Fiscal Intermediate to allow a CPP to bill for medical care as a provider.